Sinovac Biotech, Ltd (SVA) Misses Q3 EPS by 3c

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

Sinovac Biotech, Ltd (NASDAQ: SVA) reported Q3 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $12.35 million.

For earnings history and earnings-related data on Sinovac Biotech, Ltd (SVA) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
• Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook
• Target Corp. (TGT) Misses Q1 Views, Issues Mixed Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?